Vahearuanne Telescan AS vahearuanne seisuga 30. juuni

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Vahearuanne

Telescan AS vahearuanne seisuga 30. juuni 2014

2013. aasta teises ja 2014. esimeses pooles viis Telecan ellu oma strateegilise äriplaani esimese etapi. Telescani ennetava meditsiini skaneerimise tehnoloogiatel põhinev unikaalne strateegiline kava toetab tõhusalt profülaktilise tervishoiu arengut, võimaldades inimestel elada tervemalt ja kauem. Protsessi esimeses sammus analüüsime DNA biomarkerite tuntud riske - eelsoodumust ühe või mitme eluohtliku haiguse tekkeks aja jooksul. Teises etapis toimub kord või kaks aastas MRT skaneering kontrollimaks organismi tervislikku seisundit. Kui skaneerimise käigus leitakse märke algusfaasis olevatest haigustest, võimaldab varajane sekkumine saavutada palju paremaid ravitulemusi võrreldes meditsiinilise seisundiga, mil avalduvad juba kliinilised sümptomid. Telescani profülaktiline lähenemine võimaldab haiguse varajast tuvastamist ning suurendab  ravi õnnestumise tõenäosust.

Telescani kahetasandiline profülaktilise skaneerimise strateegia pakub tulutootluseks mitmekülgseid võimalusi.

Ennetava meditsiini ärimudeli edukaks turundamiseks rakendab Telescan  frantsiisiformaatiformaati, mille globaalseks väljaarendamiseks hetkel ettevalmistusi tehakse. Praeguseks on allkirjastamisel kolm frantsiisilepet, mis 6 kuu jooksul alates 1. juulist 2014 peaksid hakkama tulu tootma. Hetkel toimuvad läbirääkimised edasisteks frantsiisi turundusvõimalusteks. Eelseisva kuue kuu jooksul alustab ettevõte ka aktiivset turunduskampaaniat.

Suur osa käesolevas finantsaruandes toodud kuludest on juriidilised, majandusarvestuse ja nõustamise eest makstavad tasud, mis on seotud ettevõtte ärimudeli arendamisega.

Suurem hulk Telescani aktsiad on juba müüdud kasvava ülekursiga üle nominaalväärtuse. Plaanide kohaselt õnnestub kogu esialgne lubatud aktsiakapital 100 000 eurot täielikult ära märkida 2014 aasta lõpuks. Seejärel kavatseb ettevõte jätkata oma kapitalibaasi ehitamist uute lisainvesteeringute kaasamisega.

 Bilanss

         
eurodes 30.06.2014 31.12.2013    
         
Varad        
         
Käibevarad        
Raha 1 013 2 357    
Nõuded ja ettemaksed 8 019 6 374    
Käibevarad kokku 9 032 8 731    
         
Põhivarad        
Materiaalne põhivara 19 974 23 047    
Põhivara kokku 19 974 23 047    
         
Varad kokku 29 006 31 778    
         
Kohustused ja omakapital        
         
Omakapital        
Aktsiakapital 75 500 60 000    
Registreerimata aktsiakapital 23 000 0    
Ülekurss 35 500 10 000    
Eelmiste perioodide jaotamata kasum/- kahjum -69 930 0    
Perioodi kasum -62 564 -69 930    
Omakapital kokku 1 506 70    
         
Lühiajalised kohustused        
Võlad ja ettemaksed 27 500 31 708    
Lühiajalised kohustused kokku 27 500 31 708    
Kohustused kokku 27 500 31 708    
         
Omakapital ja kohustused kokku 29 006 31 778    
                 

Kasumiaruanne

       
eurodes 01.01-30.06.2014 30.05-30.06.2013    
         
Müügitulu 2 250 0    
Muud äritulud 1 0    
Mitmesugused tegevuskulud -56 436 -179    
Tööjõu kulud -5 301 0    
Põhivara kulum ja väärtuse langus -3 073 0    
Muud ärikulud -5 0    
Ärikasum -62 564 -179    
Kasum enne tulumaksukulu -62 564 -179    
Puhaskasum -62 564 -179    
               

Rahavoogude aruanne

       
eurodes 01.01- 30.06.2014 30.05-30.06.2013    
Rahavood äritegevusest        
Ärikasum -62 564 -179    
Põhivara kulum ja väärtuse langus 3 073 0    
Äritegevusega seotud nõuete ja ettemaksete muutus -1 645 0    
Äritegevusega seotud kohustuste ja ettemaksete muutus -4 208 179    
Kokku rahavood äritegevusest -65 344 0    
         
Rahavood investeerimistegevusest        
Tasutud materiaalse põhivara soetamisel 0 0    
Kokku rahavood investeerimistegevusest 0 0    
         
Rahavood finantseerimistegevusest        
Saadud laenud 0      
Saadud laenude tagasimaksed 0 0    
Laekunud aktsiate või osade emiteerimisest 64 000 25 000    
Kokku rahavood finantseerimistegevusest 64 000 25 000    
         
Rahavood kokku -1 344 25 000    
         
Raha ja raha ekvivalentide muutus -1 344 25 000    
Raha ja raha ekvivalendid perioodi alguses 2 357 0    
Raha ja raha ekvivalendid perioodi lõpus 1 013 25 000    
               

 Omakapitali muutuste aruanne

         
eurodes          
  Aktsiakapital Registreerimata aktsiakapital Ülekurss Jaotamata kasum/- kahjum Kokku
Saldo 30.05.2013 25 000 0 0 0 25 000
Aruandeperioodi kasum 0 0 0 -179 -179
Saldo 30.06.2013 25 000 0 0 -179 24 821
Emiteeritud aktsiakapital 35 000 0 10 000 0 45 000
Aruandeperioodi kasum 0 0 0 -69 751 -69 751
Saldo 31.12.2013 60 000 0 10 000 -69 930 70
Emiteeritud aktsiakapital 15 500 23 000 25 500 0 64 000
Aruandeperioodi kasum 0 0 0 -62 564 -62 564
Saldo 30.06.2014 75 500 23 000 35 500 -132 494 1 506

         Michael Chambers          COO          Telescan AS          +44 79 6404 8080          mc@telescan.ee

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Celcuity Inc. Prepares for Third Quarter Financial Results

Updated Category News Views 91

Celcuity Inc. Announces Upcoming Financial Results Release Celcuity Inc. (NASDAQ: CELC), a pioneering biotechnology company focused on innovative oncology therapies, has exciting news. The company will be releasing its financial results for the third quarter of 2025 after the market closes. This significant event is scheduled for a Wednesday, with management set to...

Continue Reading
EverTrue and DonorSearch Team Up to Revolutionize Fundraising

Updated Category News Views 973

EverTrue's Strategic Acquisition of DonorSearch EverTrue, a leader in donor engagement and pipeline development, recently announced a significant acquisition. The company has acquired DonorSearch, known for its innovative AI-powered donor discovery solutions. This strategic move is aimed at enhancing the capabilities of fundraising teams, enabling them to connect with...

Continue Reading
Celebrating Creativity and Inclusion: ADCOLOR Awards 2025

Updated Category News Views 315

ADCOLOR Awards 2025: A Night of Inspiration and Celebration Presented by leading organizations in the industry like Amazon, Disney, and Meta, the ADCOLOR Awards is a prestigious event celebrating remarkable individuals and organizations that champion diversity and inclusion in creative fields. This year's ceremony showcased inspiring figures such as Richelieu Dennis,...

Continue Reading
Transforming a $1000 Investment in First Solar to $3700

Updated Category News Views 161

Transform Your Investment with First Solar First Solar (NASDAQ: FSLR) has shown impressive performance over the past decade. This company has not only managed to keep pace with the market but has actually outperformed it by an average of 2.49% annually. This impressive annualized return translates to an average annual growth of 14.22%, making First Solar a notable player...

Continue Reading
Carpenter Technology Announces New Quarterly Dividend Plans

Updated Category News Views 107

Carpenter Technology Announces Quarterly Cash Dividend Carpenter Technology Corporation (NYSE: CRS), a leading name in high-performance specialty alloys, has made a significant announcement regarding its quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.20 per share on common stock, underscoring its commitment to returning value to...

Continue Reading